Established in 1972 near Bologna, the company is among the top worldwide leaders in the haemodialysis medical equipment business. It is a European leading manufacturer and distributors of dialyzers, fluids, machines and hematic lines for the treatment of renal pathologies. Bellco generated 2011 sales of approximately €110 million and an EBITDA of around €17 million. Bellco has 4 direct subsidiaries abroad (Canada, France, Spain and Belgique) and around 54% of its turnover is generated by export. The new investor will sustain Bellco in its international growth as well as market consolidation through new highly-technological and innovative products, fully complying with product and market strategies that have featured the last three years of success.